RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 21 filers reported holding RECRO PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $266,000 | -63.0% | 24,051 | -66.0% | 0.03% | -32.0% |
| Q2 2019 | $719,000 | +215.4% | 70,700 | +81.6% | 0.05% | +354.5% |
| Q1 2019 | $228,000 | -24.5% | 38,925 | -8.6% | 0.01% | -35.3% |
| Q3 2018 | $302,000 | -49.1% | 42,600 | -64.0% | 0.02% | -51.4% |
| Q2 2018 | $593,000 | +111.0% | 118,200 | +270.5% | 0.04% | +52.2% |
| Q3 2016 | $281,000 | -9.1% | 31,900 | -18.0% | 0.02% | -20.7% |
| Q2 2016 | $309,000 | -21.6% | 38,900 | -41.1% | 0.03% | -27.5% |
| Q1 2016 | $394,000 | -35.4% | 66,094 | -2.5% | 0.04% | -48.7% |
| Q4 2015 | $610,000 | +6.8% | 67,800 | +42.4% | 0.08% | +5.4% |
| Q3 2015 | $571,000 | +151.5% | 47,600 | +170.5% | 0.07% | +131.2% |
| Q2 2015 | $227,000 | – | 17,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |